TY - JOUR
T1 - MIND at Home-Streamlined
T2 - Study protocol for a randomized trial of home-based care coordination for persons with dementia and their caregivers
AU - Samus, Quincy M.
AU - Black, Betty S.
AU - Reuland, Melissa
AU - Leoutsakos, Jeannie Marie S.
AU - Pizzi, Laura
AU - Frick, Kevin D.
AU - Roth, David L.
AU - Gitlin, Laura N.
AU - Lyketsos, Constantine G.
AU - Johnston, Deirdre
N1 - Publisher Copyright:
© 2018 Elsevier Inc.
PY - 2018/8
Y1 - 2018/8
N2 - Background: Dementia is associated with high health care costs, premature long-term care (LTC) placement, medical complications, reduced quality of life, and caregiver burden. Most health care providers and systems are not yet organized or equipped to provide comprehensive long-term care management for dementia, although a range of effective symptoms and supportive care approaches exist. The Maximizing Independence at Home-Streamlined (MIND-S) is a promising model of home-based dementia care coordination designed to efficiently improve person-centered outcomes, while reducing care costs. This report describes the rationale and design of an NIA-funded randomized controlled trial to test the impact of MIND-S on time to LTC placement, person with dementia outcomes (unmet needs, behavior, quality of life), family caregiver outcomes (unmet needs, burden), and cost offset at 18 (primary end point) and 24 months, compared to an augmented usual care group. Methods: This is a 24-month, parallel group, randomized trial evaluating MIND-S in a cohort of 304 community-living persons with dementia and their family caregivers in Maryland. MIND-S dyads receive 18 months of care coordination by an interdisciplinary team comprised of trained non-clinical community workers (e.g. Memory Care Coordinators), a registered nurse, and a geriatric psychiatrist. Intervention components include in-home dementia-related needs assessments; individualized care planning; implementation of standardized evidence-based care strategy protocols; and ongoing monitoring and reassessment. Outcomes are assessed by blinded evaluators at baseline, 4.5, 9, 13.5, 18, and 24 months. Discussion: Trial results will provide rigorous data to inform innovations in effective system-level approaches to dementia care.
AB - Background: Dementia is associated with high health care costs, premature long-term care (LTC) placement, medical complications, reduced quality of life, and caregiver burden. Most health care providers and systems are not yet organized or equipped to provide comprehensive long-term care management for dementia, although a range of effective symptoms and supportive care approaches exist. The Maximizing Independence at Home-Streamlined (MIND-S) is a promising model of home-based dementia care coordination designed to efficiently improve person-centered outcomes, while reducing care costs. This report describes the rationale and design of an NIA-funded randomized controlled trial to test the impact of MIND-S on time to LTC placement, person with dementia outcomes (unmet needs, behavior, quality of life), family caregiver outcomes (unmet needs, burden), and cost offset at 18 (primary end point) and 24 months, compared to an augmented usual care group. Methods: This is a 24-month, parallel group, randomized trial evaluating MIND-S in a cohort of 304 community-living persons with dementia and their family caregivers in Maryland. MIND-S dyads receive 18 months of care coordination by an interdisciplinary team comprised of trained non-clinical community workers (e.g. Memory Care Coordinators), a registered nurse, and a geriatric psychiatrist. Intervention components include in-home dementia-related needs assessments; individualized care planning; implementation of standardized evidence-based care strategy protocols; and ongoing monitoring and reassessment. Outcomes are assessed by blinded evaluators at baseline, 4.5, 9, 13.5, 18, and 24 months. Discussion: Trial results will provide rigorous data to inform innovations in effective system-level approaches to dementia care.
UR - http://www.scopus.com/inward/record.url?scp=85048550720&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048550720&partnerID=8YFLogxK
U2 - 10.1016/j.cct.2018.05.009
DO - 10.1016/j.cct.2018.05.009
M3 - Article
C2 - 29783091
AN - SCOPUS:85048550720
SN - 1551-7144
VL - 71
SP - 103
EP - 112
JO - Contemporary Clinical Trials
JF - Contemporary Clinical Trials
ER -